Annual School of Nursing Oncology
CAR T-Cell Therapy Continues to Revolutionize Hematologic Cancer Treatment
August 31, 2021
Article
Kelly Garvin, BSN, RN, OCN, discusses the impact of CAR T-cell therapy on patients and how nurses care for them, as well as her expectations on how indications will grow.
Expert Weighs in on Future of CAR T-Cell Therapy Treatment Directions
August 18, 2021
Video
Kelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.
More Broad Molecular Tests Are Needed to Accurately Treat Non-Small Cell Lung Cancer
August 17, 2021
Article
Patients with non-small cell lung cancer driver mutations respond better to targeted treatments compared to chemotherapy, yet less than half of these patients receive next generation sequencing.
Immunotherapy Related AEs Are Manageable with Nurse Intervention
August 16, 2021
Article
“If you're an oncology nurse, you will have patients with immunotherapy–which is why we want to make sure that we are really familiar with these side effects.”
Oncology Nurses Who Proactively Manage CAR T-Cell Therapy-Related AEs Can Ensure Their Patients Remain on Treatment
August 11, 2021
Video
Proper training can help oncology nurses act as intensivists and quickly identify if their patients are experiencing any CAR T-cell therapy-related adverse events.
Understanding the Essentials of Biosimilars: What Oncology Nurses Need to Know
August 09, 2021
Article
Teresa Knoop, MSN, RN, AOCN, says it is important for oncology nurses to understand the naming convention of biosimilars as it is an important aspect of anticipating adverse events.
Durvalumab Boosts Survival Outcomes in Locally Advanced NSCLC
August 25, 2020
Article
Locally advanced non-small cell lung cancer traditionally had high relapse rates after initial treatment. Now durvalumab may bring better survival rates to these patients.
CAR T-Cell Therapy: Promising, But Not Perfect
August 19, 2020
Article
Nurses need to know the potentially life-threatening adverse events of CAR T-cell therapy.
More for Melanoma: Nurse Discusses Unmet Needs
August 18, 2020
Video
Despite many exciting advances in recent years, there are still aspects of melanoma treatment that need to be further studied and understood, said Grace Cherry, NP, a nurse practitioner at UCLA Health.
Adverse Event Management for BRAF/MEK Inhibitors in Melanoma
August 14, 2020
Article
“Nurses are our frontline as far as giving these treatments and also in teaching our patients about side effects and detecting them,” Grace Cherry, NP, MSN, RN said.